KYMERA THERAPEUTICS INC (KYMR) Stock Income Statement
NASDAQ:KYMR - Nasdaq - US5015751044 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 58.88M | 47.07M | 78.59M | 46.83M | 72.83M | |||
| Operating Expenses | 337.12M | 303.78M | 244.12M | 208.08M | 173.36M | |||
| Research and Development | 271.68M | 240.25M | 189.08M | 164.25M | 137.02M | |||
| Selling, General, and Administrative Expenses | 65.43M | 63.53M | 55.04M | 43.83M | 36.35M | |||
| Operating Income | -278.23M | -256.71M | -165.53M | -161.26M | -100.53M | |||
| Interest Income/Expense | 37.35M | 37.78M | 18.57M | 6.45M | 310.00K | |||
| Non Recurring Items | 0.00 | -4.92M | N/A | N/A | N/A | |||
| Income Before Taxes | -240.88M | -223.86M | -146.96M | -154.81M | -100.22M | |||
| Net Income | -240.88M | -223.86M | -146.96M | -154.81M | -100.22M | |||
| EBITDA | -270.27M | -249.34M | -161.97M | -158.28M | -98.13M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.10 | -2.98 | -2.52 | -2.87 | -2.09 | |||
| Non GAAP EPS | -3.10 | -2.90 | -2.52 | -2.88 | -2.06 | |||
| Statistics | ||||||||
| Profit Margin | -409.07% | -475.57% | -186.99% | -330.58% | -137.61% | |||
| Operating Profit Margin | -472.50% | -545.36% | -210.62% | -344.35% | -138.03% | |||
All data in USD